Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-7,100
Closed -$572K 535
2022
Q3
$572K Sell
7,100
-2,400
-25% -$203K 0.02% 702
2022
Q2
$708K Sell
9,500
-6,900
-42% -$630K 0.03% 616
2022
Q1
$2.1M Buy
16,400
+10,000
+156% +$1.09M 0.07% 314
2021
Q4
$859K Buy
6,400
+1,600
+33% +$230K 0.03% 606
2021
Q3
$656K Sell
4,800
-16,000
-77% -$2.02M 0.02% 865
2021
Q2
$2.22M Sell
20,800
-2,800
-12% -$269K 0.07% 380
2021
Q1
$2.12M Buy
23,600
+13,600
+136% +$1.28M 0.07% 381
2020
Q4
$924K Buy
+10,000
New +$893K 0.04% 508

Other funds holding DXCM

Point72 Hong Kong's DXCM Position: Q3 2025 in Review

Point72 Hong Kong opened a new position in DexCom (DXCM) in Q3 2025: 30,023 shares worth $2.02M. The stake represents 0.09% of the portfolio and ranks #155 among its holdings. This is a return to the name: Point72 Hong Kong previously reported a position in DXCM as recently as Q1 2025.

Point72 Hong Kong first reported a position in DXCM in Q1 2017 and has held it in 17 quarters since. The position peaked at $12.3M in Q4 2023. 911 funds tracked by Wall St. Rank hold DXCM as of Q3 2025.

  • Point72 Hong Kong held 30,023 shares of DexCom worth $2.02M as of Q3 2025.
  • DexCom was a new Point72 Hong Kong position in Q3 2025.
  • DexCom made up 0.09% of Point72 Hong Kong's portfolio in Q3 2025, its #155 holding.
  • Point72 Hong Kong first reported a position in DexCom in Q1 2017 and has held it in 17 quarters since.
  • Point72 Hong Kong's DexCom position peaked at $12.3M in Q4 2023.
  • 911 funds tracked by Wall St. Rank held DexCom as of Q3 2025.

Based on Point72 Hong Kong's 13F filing for Q3 2025, filed 14 Nov 2025.